Cancer

(More information in the various recent posts in the Cancer Category)

(More Information also under Services> Cancer Guidelines)

 

Dear Patients,

When it comes to cancer care we concentrate on the treatment with mistletoe (viscum album).

The mistletoe is arguably the most studied complementary treatment used in cancer care. In many hundreds clinical studies and laboratory experiments  benefits such as:

  • tumor cell killing effects,
  • significant improvement of survival time,
  • increased quality of life, and
  • additional strengthening of the immune system have been shown while essentially no side effects are reported.  The accompanying rise in body temperature, local reactions in the place where an injection was given, occasional headache or rare dizziness are wanted and indicate a stronger effectiveness.

Crude extracts of Mistletoe have been used for centuries for treatment of high blood pressure, infertility, nervous conditions, headaches, etc. These extracts are available in health food stores and online. They are, however, ineffective in cancer care.

Only those mistletoe preparations that have undergone specific multiple pharmacological manufacturing steps have been shown to have anti cancer actions.

The companies that follow the intricate steps needed to isolate the active anti cancer ingredients (lectins and viscotoxins) of the mistletoe extracts and to elicit an influence on the life force of the human body are situated mostly in Central Europe (Germany, Austria and Switzerland). Among them most famous are Abnoba (maker of the abnobaViscum), Hiscia (maker of the Iscador mistletoe), Helixor (maker of Helixor mistletoe), WALA (maker of Iscucin) and others.

These formulations are suited for injectable and IV administration.

The doctors at the Paulina Medical Clinic in cooperation with the research teams at the Kolisko Institute, www.koliskoinstitute.org, have recently developed a new form of oral mistletoe drops that are made in similar fashion to the injectable material and are suited for both the cancer care and the support of the mental/soul processes of the patients.

Brief introduction to our work with the mistletoe extracts:

Andrea and I began our never ending interest in the mistletoe therapy already while in our respective medical schools (1975). (I was happy to have an experimental study on the effect of mistletoe on the thymus gland (immune system) accepted for publication (see below).

After completing our hospital residency programs in the US we went to Europe where we trained in advanced mistletoe therapy with pioneering experts in the field.

Since opening the Paulina Medical Clinic in 1983 the mistletoe therapy has been a consistent part of the advice we give patients seeking a complete cancer care.

More than 10 years ago we have, together with other colleagues, established the  Kolisko Institute, www.koliskoinstitute.org, where we conduct experiments for deepening the understanding of the effectiveness of the mistletoe. We offer also and publish other webinars, hold conferences, etc.

Recently we have neared completion on oral mistletoe drops that we hope will significantly improve the overall success rate of the mistletoe therapy. An article in this regard has been accepted for publication and will appear at the beginning of 2024.

Our current protocol for cancer care consists of:

  • a careful assessment of the individual needs;
  • a triple administration of European mistletoe (injections, IV and oral drops);
  • a targeted supplementation to work synergistically with the mistletoe administration;
  • a cancer-oriented laboratory testing

Wishing you all the best in your better health quest,

R. Rentea MD

Below please see some articles related to the subject – many more to be added in the months ahead.

MISTLETOE STUDIES & FREQUENTLY ASKED QUESTIONS